Glory Health Industry Dividendos y recompras

Dividendo controles de criterios 0/6

Glory Health Industry no paga actualmente dividendo.

Información clave

Rentabilidad por dividendo

n/a

Rendimiento de la recompra

Rendimiento total para el accionista	n/a
Rendimiento futuro de los dividendos	n/a
Crecimiento de los dividendos	n/a
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	HK$0.0376
Ratio de pago	0%

Últimas actualizaciones de dividendos y recompras

No hay actualizaciones

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de 2329 han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de 2329 han aumentado.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Glory Health Industry vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de 2329 con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (2329)	0%
Suelo de mercado 25% (HK)	3.3%
Techo de mercado 25% (HK)	8.1%
Media de la industria (Real Estate)	5.9%
Analista de previsiones (2329) (hasta 3 años)	n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de 2329 en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de 2329 en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Pago de beneficios a los accionistas

Cobertura de los beneficios: 2329 no paga un dividendo notable para el mercado Hong Kong.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que 2329 no ha comunicado ningún pago.

Glory Health Industry Dividendos y recompras

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos y recompras

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Estabilidad y crecimiento de los pagos

Rentabilidad por dividendo vs. Mercado

Pago de beneficios a los accionistas

Pago en efectivo a los accionistas

Descubre empresas que pagan buenos dividendos